Table of contents 01 02 03 Hematopoietic tissues Bone marrow Erythropoiesis
What is Hemopoiesis ? Hemopoiesis means: the production of all blood cells. Erythropoiesis : erythrocytes (RBCs) Leukopoiesis : leukocytes (WBCs) Thrombopoiesis : thrombocytes (platelets)
Hematopoietic tissues 01
Hemopoietic tissues Hemopoietic tissues : the sites where new blood cells are formed. It includes: The yolk sac (Yolk sac phase) : in the 2nd week of gestation Liver (hepatic phase) : 8 weeks until 6 – 7 months of fetal life Bone marrow (bone marrow phase) : from the 2nd trimester
Bone Marrow 02
Bone marrow Bone marrow (BM) is the major location for hematopoiesis. Types of bone marrow : Red BM Yellow BM Color red due to its high content of HB yellow due to its high content of fat cells Site In fetus: most of the marrow In adults: present in epiphyses of long bones, Flat bones. Most of marrow in adults Function - Production of blood cells - Destruction of old RBCs. - Storage of fats, - In time of need, it can change into active red type. Red BM Yellow BM
Erythropoiesis Size: 12-15 Μ M Cytoplasm: mildly basophilic (ribosomes). Nucleus: large, spherical with 1-2 nucleoli. Size: 14 μ m Cytoplasm: deeply basophilic (ribosomes). Nucleus: smaller, more heterochromatic nucleus. No nucleoli seen. 1. Proerythroblast 2. Basophilic erythroblast 3. Polychromatophilic erythroblast Last cell can be divide Hemoglobin production begins. Size: 11 μ m Cytoplasm: polychromatophilic (blue & red color). Nucleus : small & deeply stained.
Erythropoiesis Size: 8 μ m Cytoplasm: acidophilic (due to Hb ). Nucleus: small, deeply stained extruded nucleus is phagocytosed by macrophages. Immature RBCs. Size: slightly larger than RBCs. Cytoplasm: still retains some polyribosomes (spots/threads) No Nucleus ˂1.5% of the total RBCs (Brilliant cresyl blue stain ). 4. Orthochromatophilic erythroblast 5. Reticulocytes 6. Erythrocytes Mature RBCs (biconcave discs.) Size: 7.5 μ m. Cytoplasm: full of Hb (acidophilic). Life span: 120 days.
This treatment is 10 times faster than previous treatments 50% Reduction in complications 10x faster 85% Success rate for the breakthrough